Marshall Wace’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Buy
1,300
+1,000
+333% +$171K ﹤0.01% 2756
2025
Q4
$50.6K Sell
300
-33,000
-99% -$5.36M ﹤0.01% 2778
2025
Q3
$4.81M Buy
+33,300
New +$4.55M ﹤0.01% 1197
2024
Q4
Sell
-2,200
Closed -$320K 2764
2024
Q3
$320K Sell
2,200
-29,700
-93% -$4.3M ﹤0.01% 2108
2024
Q2
$4.38M Buy
31,900
+29,400
+1,176% +$3.92M 0.01% 1054
2024
Q1
$339K Buy
+2,500
New +$341K ﹤0.01% 2072
2022
Q4
Sell
-2,700
Closed -$316K 3150
2022
Q3
$316K Sell
2,700
-4,300
-61% -$534K ﹤0.01% 2931
2022
Q2
$823K Buy
+7,000
New +$831K ﹤0.01% 2548
2021
Q4
Sell
-2,200
Closed -$356K 4042
2021
Q3
$356K Sell
2,200
-21,800
-91% -$3.67M ﹤0.01% 2570
2021
Q2
$3.93M Buy
+24,000
New +$3.7M 0.02% 989
2021
Q1
Sell
-186,000
Closed -$28.2M 2644
2020
Q4
$28.2M Buy
+186,000
New +$26.6M 0.15% 131

Other funds holding IBB